glp-1 kidney disease Real-World Evidence for Receptor Agonists Across the CKD Spectrum – AJKD Blog New Guideline Puts Some at

GLP-1s affect metabolism, digestion, and appetite

Patients experiencing persistent changes should consult their healthcare providers, who can: Monitor hormone levels Adjust medication dosage if needed Recommend appropriate management strategies The relationship between Ozempic or Wegovy and hormonal function continues to be studied, with research showing both direct and indirect effects on the endocrine system

GLP-1R activation improves glucose control via enhanced glucose-stimulated insulin secretion [1113], slowed gastric emptying [13, 14], and decreased plasma glucagon levels [13]

Lpez-Padrs C, Salord N, Alves C, et al

Undoubtedly, the discovery of how glucagon-like peptide-1 (GLP-1) agonists work has been one of the most impactful breakthroughs in recent times

GLP-1RAs have now become a part of an emerging treatment approach for obesity, with liraglutide being the first GLP-1RA approved by the US Food and Drug Administration (FDA) in December 2014